Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Elizabeth Dunbar
ST. PAUL, Minn.

Under fire, Accretive plans data release

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

The health contractor under investigation by the Minnesota Attorney General plans to release more information about the case Friday.

Sen. Al Franken had asked Accretive Health to answer questions about its debt collection activities.

His inquiry came after Attorney General Lori Swanson leveled a series of allegations against the Chicago-based company, including that the company violated state and federal patient privacy and debt collection laws by seeking payment from patients at their bedsides and in the emergency room.

Accretive Health has denied the allegations and told market analysts this week that the truth will come out. The company has also asked a federal judge to dismiss the lawsuit the attorney general filed earlier this year.

Accretive Health has seen a sharp drop in its stock price amid the allegations, and company officials have issued more conservative estimates for revenues this year.